Overactive Bladder Syndrome Research 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
Sacral neuromodulation in the golden years: Treatment outcomes in elderly 75 years and older
CONCLUSIONS: SNM is a safe and effective option in well-selected patients over the age of 75 years. Treatment success rate is comparable to younger cohorts. Advanced age should not preclude third-line therapy options in this population.PMID:37931277 | DOI:10.5489/cuaj.8421 (Source: Canadian Urological Association Journal)
Source: Canadian Urological Association Journal - November 6, 2023 Category: Urology & Nephrology Authors: Roseanne Ferreira Samuel Otis-Chapados Emad Alwashmi Naeem Bhojani Kevin C Zorn Bilal Chughtai Dean S Elterman Source Type: research
